IIM
ACAD icon

INTECH Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

INTECH Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
42,956
+10,078
+31% +$222K 0.01% 993
2026
Q1 		$732K Sell
32,878
-15,372
-32% -$367K 0.01% 1156
2025
Q4 		$1.29M Hold
48,250
– – 0.01% 983
2025
Q3 		$1.03M Sell
48,250
-27,160
-36% -$642K 0.01% 1143
2025
Q2 		$1.63M Sell
75,410
-462
-0.6% -$8.59K 0.02% 898
2025
Q1 		$1.26M Buy
75,872
+23,766
+46% +$432K 0.01% 1053
2024
Q4 		$956K Buy
52,106
+14,423
+38% +$233K 0.01% 1183
2024
Q3 		$580K Buy
+37,683
New +$629K 0.01% 1149

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

INTECH Investment Management's ACAD Position: Q2 2026 in Review

INTECH Investment Management increased its Acadia Pharmaceuticals (ACAD) stake by 31% in Q2 2026, buying an estimated $222K and bringing the position to 42,956 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #993.

INTECH Investment Management first reported a position in ACAD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.63M in Q2 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • INTECH Investment Management held 42,956 shares of Acadia Pharmaceuticals worth $1.09M as of Q2 2026.
  • INTECH Investment Management bought 10,078 Acadia Pharmaceuticals shares in Q2 2026, an estimated $222K.
  • Acadia Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #993 holding.
  • INTECH Investment Management first reported a position in Acadia Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Acadia Pharmaceuticals position peaked at $1.63M in Q2 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.